The Turkish Pharmaceuticals and Medical Devices Authority recently published the (1) Guideline on the Classification of Diversification and Variation Applications; (2) Guideline on Communication, Organization and Responsibilities of Stakeholders in Market Control Programs; (3) Guideline on the Good Manufacturing Practices in Human Medicinal Products Manufacturing Plants; (4) Announcement on Annotation/Revision Procedures and Transition to the New Type Licenses; and (5) updated the Precautions to Adopt in Clinical Trials against the COVID-19 Pandemic.